this study suggests that gallbladder motility is closely correlated with cholesterol gallstone formation , and administration of exogenous cholecystokinin-octapeptide can effectively prevent gallbladder stasis and reduce the incidence of cholelithiasis .
C0016976
gallbladder
C0008350
cholelithiasis